Chloramphenicol-induced mitochondrial stress increases p21 expression and prevents cell apoptosis through a p21-dependent pathway

J Biol Chem. 2005 Jul 15;280(28):26193-9. doi: 10.1074/jbc.M501371200. Epub 2005 May 19.

Abstract

Pretreatment of HepG2 and H1299 cells with chloramphenicol rendered the cells resistant to mitomycin-induced apoptosis. Both mitomycin-induced caspase 3 activity and PARP activation were also inhibited. The mitochondrial DNA-encoded Cox I protein, but not nuclear-encoded proteins, was down-regulated in chloramphenicol-treated cells. Cellular levels of the p21(waf1/cip1) protein and p21(waf1/cip1) mRNA were increased through a p53-independent pathway, possibly because of the stabilization of p21(waf1/cip1) mRNA in chloramphenicol-treated cells. The p21(waf1/cip1) was redistributed from the perinuclear region to the cytoplasm and co-localized with mitochondrial marker protein. Several morphological changes and activation of the senescence-associated biomarker, SA beta-galactosidase, were observed in these cells. Both p21(waf1/cip1) antisense and small interfering RNA could restore apoptotic-associated caspase 3 activity, PARP activation, and sensitivity to mitomycin-induced apoptosis. Similar effects were seen with other antibiotics that inhibit mitochondrial translation, including minocycline, doxycycline, and clindamycin. These findings suggested that mitochondrial stress causes resistance to apoptosis through a p21-dependent pathway.

MeSH terms

  • Anti-Bacterial Agents / pharmacology
  • Apoptosis*
  • Biomarkers / metabolism
  • Blotting, Western
  • Caspase 3
  • Caspases / metabolism
  • Cell Cycle Proteins / genetics
  • Cell Cycle Proteins / metabolism
  • Cell Cycle Proteins / physiology*
  • Cell Line, Tumor
  • Cell Nucleus / metabolism
  • Cellular Senescence
  • Chloramphenicol / pharmacology*
  • Clindamycin / pharmacology
  • Cyclin-Dependent Kinase Inhibitor p21
  • Cyclooxygenase 1
  • Cytochromes c / metabolism
  • Cytoplasm / metabolism
  • DNA / chemistry
  • DNA Damage
  • DNA, Complementary / metabolism
  • Down-Regulation
  • Doxycycline / pharmacology
  • Enzyme Activation
  • Enzyme Inhibitors / pharmacology
  • G1 Phase
  • Genes, Reporter
  • Humans
  • Membrane Potentials
  • Membrane Proteins
  • Microscopy, Fluorescence
  • Minocycline / pharmacology
  • Mitochondria / enzymology
  • Mitochondria / metabolism
  • Mitochondria / pathology*
  • Mitomycin / pharmacology
  • Oligonucleotides, Antisense / chemistry
  • Plasmids / metabolism
  • Poly(ADP-ribose) Polymerases / metabolism
  • Promoter Regions, Genetic
  • Prostaglandin-Endoperoxide Synthases / metabolism
  • Protein Biosynthesis
  • Protein Synthesis Inhibitors / pharmacology*
  • RNA / metabolism
  • RNA, Messenger / metabolism
  • RNA, Small Interfering / metabolism
  • Reverse Transcriptase Polymerase Chain Reaction
  • Ribosomes / chemistry
  • Transfection
  • Tumor Suppressor Protein p53 / metabolism
  • beta-Galactosidase / metabolism

Substances

  • Anti-Bacterial Agents
  • Biomarkers
  • CDKN1A protein, human
  • Cell Cycle Proteins
  • Cyclin-Dependent Kinase Inhibitor p21
  • DNA, Complementary
  • Enzyme Inhibitors
  • Membrane Proteins
  • Oligonucleotides, Antisense
  • Protein Synthesis Inhibitors
  • RNA, Messenger
  • RNA, Small Interfering
  • Tumor Suppressor Protein p53
  • Clindamycin
  • Mitomycin
  • RNA
  • Chloramphenicol
  • Cytochromes c
  • DNA
  • Cyclooxygenase 1
  • PTGS1 protein, human
  • Prostaglandin-Endoperoxide Synthases
  • Poly(ADP-ribose) Polymerases
  • beta-Galactosidase
  • CASP3 protein, human
  • Caspase 3
  • Caspases
  • Minocycline
  • Doxycycline